Independent data monitoring committees: Preparing a path for the future

American Heart Journal

Volumn 168, Issue 2, 2014, Pages

  Hess, Connie N ^a   Roe, Matthew T ^a   Gibson, C Michael ^b   J Temple, Robert ^c   Pencina, Michael J ^a   Zarin, Deborah A ^d   Anstrom, Kevin J ^b   Alexander, John H ^a   Sherman, Rachel E ^c   Fiedorek, Fred T ^e   Mahaffey, Kenneth W ^f   Lee, Kerry L ^a   Chow, Shein Chung ^g   Armstrong, Paul W ^h   Califf, Robert M ^g  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

^e BRISTOL MYERS SQUIBB   (United States)

^f STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL RESEARCH; CONFIDENTIALITY; CONFLICT OF INTEREST; CONSENSUS DEVELOPMENT; DRUG INDUSTRY; GOVERNMENT; HUMAN; LAW SUIT; NATIONAL HEALTH ORGANIZATION; PATIENT SAFETY; PRIORITY JOURNAL; PROFESSIONAL STANDARD; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; STUDY DESIGN;

CLINICAL TRIALS DATA MONITORING COMMITTEES; COMMUNICATION; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84905095178     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2014.05.003     Document Type: Article

References (16)

1. Organization, review, and administration of cooperative studies (Greenberg Report): a report from the Heart Special Project Committee to the National Advisory Heart Council, May 1967 Control Clin Trials 9 1988 137 148
2. U.S. Department of Health and Human Services, U.S. Food and DrugAdministration, and Center for Biologics Evaluation and Research et al. Guidance for clinical trial sponsors - establishment and operation of clinical trial data monitoring committees 2006 http://www.fda.gov/RegulatoryInformation/ Guidances/ucm127069.htm
3. M.R. Sydes, D.G. Altman, and A.B. Babiker et al. Reported use of data monitoring committees in the main published reports of randomized controlled trials: a cross-sectional study Clin Trials 1 2004 48 59
4. R.M. Califf, D.A. Zarin, and J.M. Kramer et al. Characteristics of clinical trials registered in ClinicalTrials.gov, 2007-2010 JAMA 307 2012 1838 1847
5. D.A. Zarin Viewpoint of ClinicalTrials.gov on IDMCs. Presented at Independent Data Monitoring Committee Training on January 16-17 2013 Duke Clinical Research Institute Durham, NC
6. D.A. Zarin, T. Tse, and R.J. Williams et al. The ClinicalTrials.gov results database - update and key issues N Engl J Med 364 2011 852 860
7. J.H. Alexander, R.D. Lopes, and S. James et al. Apixaban with antiplatelet therapy after acute coronary syndrome N Engl J Med 365 2011 699 708
8. G.G. Schwartz, A.G. Olsson, and M. Abt et al. Effects of dalcetrapib in patients with a recent acute coronary syndrome N Engl J Med 367 2012 2089 2099
9. P. Tricoci, Z. Huang, and C. Held et al. Thrombin-receptor antagonist vorapaxar in acute coronary syndromes N Engl J Med 366 2012 20 33
10. S.S. Ellenberg, T.R. Fleming, and D.L. DeMets Data monitoring committees in clinical trials: a practical perspective (statistics in practice) 2002 John Wiley & Sons, LTD Chichester, England
11. DAMOCLES Study Group, and NHS Health Technology Assessment Programme A proposed charter for clinical trial data monitoring committees: helping them to do their job well Lancet 365 2005 711 722
12. J. Herson Data and safety monitoring committees in clinical trials 2009 Chapman and Hall/CRC Boca Raton, FL
13. R. Peto, J. Emberson, and M. Landray et al. Analyses of cancer data from three ezetimibe trials N Engl J Med 359 2008 1357 1366
14. D.L. DeMets, T.R. Fleming, and F. Rockhold et al. Liability issues for data monitoring committee members Clin Trials 1 2004 525 531
15. P.W. Armstrong, and R.M. Califf Data and safety monitoring boards: academic credit where credit is due? JAMA 310 2013 1563 1564
16. J. Drazen Quoted by: Herper M. New cancer data shine spotlight on the secret committees that make medicine's toughest decisions. Forbes Magazine (online) 2012 http://www.forbes.com/sites/matthewherper/2012/06/04/new-cancer- data-shine-spotlight-on-the-secret-committees-that-make-medicines-toughest- decisions/